TABLE 2

Comparison of Clinical and Laboratory Characteristics (Median and IQR) During the First 4 d After HUS Diagnosis of Controls and of Patients Addressed to Early FI

GroupDay 0Day 1Day 2Day 3Day 4
Wt (kg)A17.0 (12.4–19.2)17.6 (12.7–20.5)17.0 (12.3–19.4)17.3 (12.4–20.1)17.3 (12.3–19.8)
B14.4 (11.1–23.7)16.1 (12.5–24.9)16.2 (12.8–25.3)15.8 (12.1–26.2)15.8 (12.2–26.4)
SBP (mm Hg)A110 (100–122)105 (95–119)105 (99–115)110 (100–119)112 (101–129)
B109 (103–119)109 (100–113)109 (101–116)105 (97–116)104 (96–111)
DBP (mm Hg)A70 (60–78)65 (54–77)61 (58–68)68 (61–76)70 (57–77)
B69 (60–74)68 (60–75)68 (64–74)69 (59–75)68 (58–75)
PTL (×103/mm3)A67 (42–110)59 (36–78)67 (49–94)78 (38–112)102 (55–130)
B48 (32–87)39 (24–74)39 (25–88)43 (20–87)56 (27–106)
LDH (U/L)A3756 (1722–5192)4164 (2480–5352)5256 (2695–5898)3989 (2156–5931)3854 (2316–6382)
B2460* (994–3800)2311* (1455–3838)2433* (1463–3982)2360* (1343–3953)2179* (1180–3437)
sCr (mg/dL)A2.0 (1.1–3.3)2.5 (1.5–4.1)3.5 (1.4–4.5)3.4 (1.2–5.3)3.5 (1.2–4.2)
B1.4* (0.7–2.1)1.5* (0.7–2.5)1.3* (0.6–3)1.5* (0.5–3.4)1.2 (0.5–3.7)
Serum urea (mg/dL)A122 (78–203)155 (105–198)161 (122–203)137 (114–212)127 (92–168)
B105 (56–142)107* (66–135)111* (57–172)106 (38–167)90 (38–182)
Serum uric acid (mg/dL)A8.7 (6.7–11.1)10.7 (8.1–11.5)9.8 (7.9–12)9.3 (7.4–11.9)7.5 (6.1–9.5)
B8.6 (6.3–9.8)8.3* (6.5–9.3)7.8* (5–9.4)6.7 (5–10.6)6.8 (4.9–10.5)
  • DBP, diastolic blood pressure; PTL, platelet count; SBP, systolic blood pressure.

  • * P < .05 versus Group A.